CHAPTER VIII

PRELIMINARY WORKING BIBLIOGRAPHY

[1] Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and

epidemiology of 2019 novel coronavirus: implications for virus origins and

receptor binding. Lancet. 2020;395(10224):565–74.

[2] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus

from patients with pneumonia in China, 2019. N Engl J Med.

2020;382(8):727–33.

[3] Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of

pneumonia. Respirology. 2018;23(2):130–7.

[4] Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia

outbreak associated with a new coronavirus of probable bat origin. Nature.

2020. https://doi.org/10.1038/ s41586-020-2012-7. 

[5] Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of

2019-nCoV in Italy: where they come from? J Med Virol. 2020:1–4.

https://doi.org/10.1002/jmv.25699

[6] Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos

G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus

(2019-nCoV) rejects the hypothesis of emergence as a result of a recent

recombination event. Infect Genet Evol. 2020;79:104212.

[7] Hampton T. Bats may be SARS reservoir. JAMA. 2005;294(18):2291.

[8] Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and

coronaviruses. Viruses. 2019;11(1):E41. https://doi.org/10.3390/v11010041.

36
[9] Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural

reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–9.

[10] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new

coronavirus associated with human respiratory disease in China. Nature.

2020. https://doi.org/10.1038/s41586-020-2008-3

[11] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical

characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.

[12] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics

of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia

in Wuhan, China. JAMA. 2020.

[13] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of

patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.

2020;395(10223):497–506.

[14] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological

and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia

in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.

[15] Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major

outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med.

2003;348(20):1986–94.

[16] Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-

Barrak A, et al. Epidemiological, demographic, and clinical characteristics of

47 cases of Middle East respiratory syndrome coronavirus disease from

Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–61.

37
[17] Wang H, Xiao X, Lu J, Chen Z, Li K, Liu H, et al. Factors associated with

clinical outcome in 25 patients with avian influenza a (H7N9) infection in

Guangzhou, China. BMC Infect Dis. 2016;16(1):534.

[18] Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical

characteristics of novel coronavirus cases in tertiary hospitals in Hubei

Province. Chin Med J. 2020. https://doi.org/10.1097/CM9.0000000000000744

[19] Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT

imaging features of 2019 novel coronavirus (2019-nCoV). Radiology.

2020;200230. https://doi.org/10.1148/radiol.2020200230.

[20] Liu J, Liao X, Qian S et al. Community transmission of severe acute

respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect

Dis 2020 doi.org/10.3201/eid2606.200239

[21] Chan J, Yuan S, Kok K et al. A familial cluster of pneumonia associated

with the 2019 novel coronavirus indicating person-to-person transmission: a

study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9

[22] Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China,

of novel coronavirus-infected pneumonia. N Engl J Med 2020;

doi:10.1056/NEJMoa2001316.

[23] Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M,et

al. Active monitoring of persons exposed to patients with confirmed COVID-

19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep.

2020 doi : 10.15585/mmwr.mm6909e1external icon

38
[24] World Health Organization. Report of the WHO-China Joint Mission on

Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet].

Geneva: World Health Organization; 2020 Available from:

https://www.who.int/docs/default- source/coronaviruse/who-china-joint-

mission-on-covid-19-final-report.pdf

[25] Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS, et al. Air, surface

environmental, and personal protective equipment contamination by severe

acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic

patient. JAMA. 2020 Mar 4 [Epub ahead of print].

[26] Wang W, Xu Y, Ruqin G, et al. Detection of SARS-CoV-2 in Different

Types of Clinical Specimens. JAMA2020 doi:10.1001/jama.2020.3786.

[27] Lauer SA, Grantz KH, Bi Q et al. The Incubation Period of Coronavirus

Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases:

Estimation and Application. Ann Intern Med2020 doi: 10.7326/M20-0504.

[28] Liu Y, Yan LM, Wan L et al. Viral dynamics in mild and severe cases of

CVOID-19. Lancet Infect Dis doi.org/10.1016/S1473-3099(20)30232-2

[29] Wolfel R, Corman V, Guggemos W et al Virological assessment of

hospitalized cases of coronavirus disease 2019. doi:

10.1101/2020.03.05.20030502.

[30] Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with

the 2019 novel coronavirus indicating possible person-to-person transmission

during the incubation period. J Infect 2020 doi: 10.1093/jiaa077

39
[31] Huang R, Xia J, Chen Y, Shan C, Wu C. A family cluster of SARS-CoV-2

infection involving 11 patients in Nanjing, China Lancet Infect Dis 2020 doi:

10.1016/ S1473-3099(20)30147-X

[32] Pan X, Chen D, Xia Y et al. Asymptomatic cases in a family cluster with

SARS-CoV-2 infection. Lancet Infect Dis 2020 doi: 10.1016/ S1473-

3099(20)30114-6

[33] Tong Z-D, Tang A, Li K-F, Li P, Wang H-L, Yi J-P, et al. Potential

presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China,

2020. Emerg Infect Dis. 2020 doi: 10.3201/eid2605.200198

[34] Wei WE, Li Z, Chiew CJ, Yong SE, et al. Presymptomatic Transmission of

SARS-CoV-2 —Singapore, January 23–March 16, 2020. MMWR, 1 April

2020/69.

[35] Kimball A, Hatfield KM, Arons M, James A, et al. Asymptomatic and

Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care

Skilled Nursing Facility —King County, Washington, March 2020. MMWR, 3

April 2020, 69(13);377–381.

[36] World Meters, Covid-19 Coronavirus Pandemic, available at

https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?

%20

[37] Barbera J, Macintyre A, Gostin L, Inglesby T, O'Toole T, DeAtley C, Tonat

K, Layton M: Large-Scale Quarantine Following Biological Terrorism in the

United States: Scientific Examination, Logistic and Legal Limits, and Possible

Consequences. JAMA. 2001, 286: 2711-2717. 10.1001/jama.286.21.2711.

40
[38] Reich DS: Modernizing local responses to public health emergencies:

Bioterrorism, epidemics, and the Model State Emergency Health Powers Act.

Journal of Contemporary Health Law and Policy. 2003, 19: 379-414.

[39] Lemon SM, Hamburg MA, Sparling PF, Choffnes ER, Mack A: Ethical and

legal considerations in mitigating pandemic disease: workshop summary.

2007, Washington, DC: Institute of Medicine. National Academy of Sciences

[40] Schabas R: Severe acute respiratory syndrome: Did quarantine help?.

Can J Infect Dis Med Microbiol. 2004, 15 (4): 204-

[41] Knobler S, Mahmoud A, Lemon S, Pray L, Eds: The Global Application of

Knowledge, Tools, and Technology: Opportunities and Obstacles. The Impact

of Globalization on Infectious Disease Emergence and Control: Exploring the

Consequences and Opportunities Workshop Report. 2006, Washington, DC:

Institute of Medicine, National Academy of Sciences, 80-124.

[42] Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP: Dynamically Modeling

SARS and Other Newly Emerging Respiratory Illnesses: Past, Present and

Future. Epidemiology. 2005, 16: 791-801.

10.1097/01.ede.0000181633.80269.4c.

[43] Bensimon CM, Upshur RE: Evidence and effectiveness in decision making

for quarantine. American Journal of Public Health. 2007, 97: S44-S48.

10.2105/AJPH.2005.077305.

[44] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al. Genomic

characterization and epidemiology of 2019 novel coronavirus: implications for

virus origins and receptor binding Lancet (2020).

41
[45] P. Zhou, X.L. Yang, X.G. Wang, B. Hu, L. Zhang, W. Zhang, et al.A

pneumonia outbreak associated with a new coronavirus of probable bat origin

Nature (2020).

[46] Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, et al. Early

transmission dynamics in Wuhan, China, of novel coronavirus-infected

pneumonia N Engl J Med, 382 (13) (2020), pp. 1199-1207

[47] W. Yu, G. Tang, L. Zhang, R. Corlett Decoding the evolution and

transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using

whole genomic data ChinaXiv (2020)

[48] J.F. Chan, S. Yuan, K.H. Kok, K.K. To, H. Chu, J. Yang, et al.A familial

cluster of pneumonia associated with the 2019 novel coronavirus indicating

person-to-person transmission: a study of a family cluster Lancet (2020)

[49] A. Kramer, I. Schwebke, G. Kampf How long do nosocomial pathogens

persist on inanimate surfaces? A systematic review BMC Infect Dis, 6 (2006),

p. 130

[50] G. Kampf, D. Todt, S. Pfaender, E. Steinmann Persistence of

coronaviruses on inanimate surfaces and its inactivation with biocidal agents

J Hosp Infect (2020)

[51] C. Rothe, M. Schunk, P. Sothmann, G. Bretzel, G. Froeschl, C. Wallrauch,

et al. Transmission of 2019-nCoV infection from an asymptomatic contact in

Germany N Engl J Med (2020)

[52] K. Kupferschmidt Study claiming new coronavirus can be transmitted by

people without symptoms was flawed Science news (2020)

42
[53] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al. Clinical features of

patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395

(10223) (2020), pp. 497-506

[54] D.K.W. Chu, Y. Pan, S.M.S. Cheng, K.P.Y. Hui, P. Krishnan, Y. Liu, et al.

Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak

of pneumonia Clin Chem (2020)

[55] Global surveillance for human infection with novel coronavirus (2019-

nCoV) World Health Organization (2020)

[56] C. Bauch, T. OrabyAssessing the pandemic potential of MERS-CoV

Lancet, 382 (9893) (2013), pp. 662-664

[57] S. Riley, C. Fraser, C.A. Donnelly, A.C. Ghani, L.J. Abu-Raddad, A.J.

Hedley, et al. Transmission dynamics of the etiological agent of SARS in

Hong Kong: impact of public health interventions Science, 300 (5627) (2003),

pp. 1961-1966

[58] Y. Yang, J.D. Sugimoto, M.E. Halloran, N.E. Basta, D.L. Chao, L. Matrajt,

et al. The transmissibility and control of pandemic influenza A (H1N1) virus

Science, 326 (5953) (2009), pp. 729-733

[59] Y. Liu, A. Gayle, A. Wilder-Smith JR. The reproductive number of COVID-

19 is higher compared to SARS coronavirus J Travel Med (2020),

10.1093/jtm/taaa021

[60] A. Kucharski, C. Althaus The role of super spreading in Middle East

respiratory syndrome coronavirus (MERS-CoV) transmission Euro Surveill, 20

(25) (2015) pii:21167

43
[61] H.E.A. Chen Clinical characteristics and intrauterine vertical transmission

potential of COVID-19 infection in nine pregnant women: a retrospective

review of medical records Lancet (2020), 10.1016/S0140-6736(20)30360-3

[62] D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, et al. Clinical

characteristics of 138 hospitalized patients with 2019 novel coronavirus-

infected pneumonia in Wuhan, China JAMA (2020)

[63] Y. Bai, L. Yao, T. Wei, F. Tian, D.Y. Jin, L. Chen, et al. Presumed

asymptomatic carrier transmission of COVID-19 JAMA (2020)

[64] Chang, M. Lin, L. Wei, L. Xie, G. Zhu, C.S. Dela Cruz, et al. Epidemiologic

and clinical characteristics of novel coronavirus infections involving 13

patients outside Wuhan, China JAMA (2020)

[65] N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, et al. Epidemiological

and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia

in Wuhan, China: a descriptive study Lancet (2020)

[66] W. Liu, Q. Zhang, J. Chen, R. Xiang, H. Song, S. Shu, et al. Detection of

Covid-19 in children in early January 2020 in Wuhan, China N Engl J Med,

382 (14) (2020), pp. 1370-1371

[67] J.F.-W. Chan, S. Yuan, K.-H. Kok, K.K.-W. To, H. Chu, J. Yang, et al.A

familial cluster of pneumonia associated with the 2019 novel coronavirus

indicating person-to-person transmission: a study of a family cluster Lancet

(2020)

[68] C.D.C. China, Epidemic update and risk assessment of 2019 novel

coronavirus Chinese Center for Diseases Control and Prevention (2020)

44
 http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf

[accessed 18 May 2020]

[69] A. Patel, D.B. Jernigan, Initial public health response and interim clinical

guidance for the 2019 novel coronavirus outbreak—United States, December

31, 2019–February 4, 2020 ,MMWR Morb Mortal Wkly Rep, 69 (2020), p. 140

[70] J.W. Tang, P.A. Tambyah, D.S.C. Hui, Emergence of a novel coronavirus

causing respiratory illness from Wuhan, China J Infect (2020)

[71] P. Habibzadeh, E.K. StonemanThe novel coronavirus: a bird's eye view Int

J Occup Environ Med, 11 (2) (2020), pp. 65-71

[72] Organization WH Global surveillance for human infection with novel

coronavirus (2019-nCoV) (2020)

[73] C. Gidengil, A. Parker, B. Zikmund-Fisher, Trends in risk perceptions and

vaccination intentions: a longitudinal study of the first year of the H1N1

pandemic Am J Public Health, 102 (2012), pp. 672-679

[74] Organization WH, Clinical management of severe acute respiratory

infection when novel coronavirus (2019-nCoV) infection is suspected (2020)

[75] C. Russell, J. Millar, J. Baillie, Clinical evidence does not support

corticosteroid treatment for 2019-nCoV lung injury Lancet, 395 (10223)

(2020), pp. 473-475

[76] C.I. Paules, H.D. Marston, A.S. Fauci, Coronavirus infections – more than

just the common cold JAMA (2020)

45
[77] M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, et

al. First case of 2019 novel coronavirus in the United States N Engl J Med

(2020)

[78] Z. Wang, X. Chen, Y. Lu, F. Chen, W. Zhang, Clinical characteristics and

therapeutic procedure for four cases with 2019 novel coronavirus pneumonia

receiving combined Chinese and Western medicine treatment Biosci Trends

(2020)

[79] M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, et al.Remdesivir and

chloroquine effectively inhibit the recently emerged novel coronavirus (2019-

nCoV) in vitro Cell Res (2020)

[80] E. de Wit, F. Feldmann, J. Cronin, R. Jordan, A. Okumura, T. Thomas, et

al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus

macaque model of MERS-CoV infection Proc Natl Acad Sci USA, 3 (2020), p.

20192208

[81] X. Liu, X.-J. Wang, Potential inhibitors for 2019-nCoV coronavirus M

protease from clinically approved medicines bioRxiv (2020)

2020.2001.2029.924100

[82] H. Lu, Drug treatment options for the 2019-new coronavirus (2019-nCoV)

Biosci Trends (2020)

[83] World Health Organization (2012), Rapid Risk Assessment of Acute Public

Health Events, available at https://apps.who.int/iris/bitstream/handle

/10665/70810/WHO_HSE_GAR_ARO_2012.1_eng.pdf?sequence=1

46